Allogeneic bone marrow transplantation in children with acute lymphoblastic leukaemia in the first and second complete remission conditioned with fractionated total body irradiation and cyclophosphamide or etoposide

Reports of Practical Oncology and Radiotherapy

Volumn 7, Issue 3, 2002, Pages 117-125

  Wachowiak, Jacek ^a   Malicki, Julian ^b   Buczkowski, Dariusz ^a   Stryczyńska, Grazyna ^b   Kosicka, Grazyna ^b   Leda, Michał ^a   Pieczonka, Anna ^a  

^a Institute of Paediatrics   (Poland)

^b Great Poland Cancer Centre   (Poland)

Author keywords

Acute lymphoblastic leukaemia; Allogeneic bone marrow transplantation; Fractionated total body irradiation

Indexed keywords

EID: 0345816631     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(02)70986-3     Document Type: Article

References (39)

1. Kowalczyk JR. Epidemiologia i etiopatogeneza białaczek. In: Radwańska U (ed.) Białaczki u dzieci. Volumed, Wrocław, 1998;17-39.
2. Radwańska U. Ostra białaczka limfoblastyczna. In: Radwańska U (ed.) Białaczki u dzieci. Volumed, Wrocław, 1998;17-39.
3. Felix CA, Lange BJ, Chessells JM. Pediatric acute lymphoblastic leukemia: challenges and controversies in 2000. "Hematology 2000" - Am Soc Hematol Educ Program, San Francisco, 1-5 grudnia 2000; 285-302.
4. Schrappe M, Camitta B, Pui C-H, Eden T, Gaynon P, Gustafsson G, et al. Long-term results of large pros-pective trials in childhood acute lymphobla-stic leukemia. Leukemia 2000;14:2193-4.
5. Chessels JC. Relapsed acute lymphoblastic leukemia: bone marrow transplant or conventional treatment? In: "Hematology 2000" - Am Soc Hematol Educ Program, San Francisco, 1-5th December 2000,291-4.
6. Chybicka A, Bogusławska-Jaworska J, Gorczyńska E, et al. Wste{ogonek}pne wyniki leczenia I nawrotu ostrej białaczki limfoblastycznej wg programu BFM 96 u dzieci w materiale Polskiej Pediatrycznej Grupy ds. Leczenia Białaczek i Chłoniaków. Med. Wieku Rozw 2000;4 (suppl 2):43-8.
7. Niethammer D. Childhood leukaemias. Oncol Rev 1996;11:15-6.
8. Wachowiak J, Bogusławska-Jaworska J, Kowalczyk JR, et al. Hematopoietic stem cell transplantation in Polish pediatric centers - development and current status. Med Sci Monitor 2000;6 (suppl. 2):4.
9. Tutschka PJ, Copelan EA, Klein JP: Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimens. Blood 1987;70:1382-8.
10. Wachowiak J, Bettoni C, Lange A, Malicki J, Kaczmarek-Kanda M, Głuszak B, et al. Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia? Acta Haematol Pol 1995;26: 377-84.
11. Skoczeń S, Klus K, Armata J, Kowalczyk J, Jackowska T, Wiśniewska-Ślusarz H, Kolecki P, et al. High risk acute lymphoblastic leukaemia in children. Preliminary report after introducing a new version of New York (1997) protocol adjusted to the age of the patients - report of the Polish Paediatric Leukaemia/Lymphoma Study Group. Med Wieku Rozwoj 2000; 4 (suppl. 2):23-32.
12. Bogusławska-Jaworska J, Chybicka A, Strzelczyk R, et al. Sześcioletnie doświadczenia w leczeniu pierwszego nawrotu ostrej białaczki limfoblastycznej u dzieci w materiale Polskiej Grupy Pediatrycznej ds. Leczenia Białaczek i Chłoniaków. Ped Pol 1994;69:711-9.
13. Malicki J. The accuracy of dose determination during total body irradiation. Strahlenther Onkol 1999;175:492-6.
14. Malicki J, Wachowiak J, Kosicka G, Stryczyńska G, Nowak A, Pracz J. Total body irradiation before bone marrow transplantation: aims and results. Adv Exp Med Biol 2001;495:277-82.
15. Malicki J, Kosicka G, Stryczyńska G, Wachowiak J. Cobalt 60 versus 15 MeV photons during total body irradiation: doses in the critical organs and complexity of the procedure. Ann Transplant 2001;6: 18-22.
16. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Lerner KG, et al. Clinical manifestatios of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974;18:295-304.
17. Schulman HM, Sullivan KM, Weiden PL, Witherspoon RP, Mc Donald GB, Schubert MM, et al. Chronic graft- versus-host disease syndrome in man. A long term clinical pathological study of 20 Seattle patients. Am J Med 1980;69:204-12.
18. Bearman SL, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, et al. Regimen-related toxicities in patients undergoing bone marrow transplantation. J Clin Oncol 1988;6:1562-8.
19. Davies SM, Ramsay NKC, Kersey JH. Allogeneic transplantation for acute lymphoblastic leukemia in children. In: Hematopoietic cell transplantation. Red. Thomas ED, Blume KG, Forman SJ. Blackwell Science, Malden, 1999;859-71.
20. Goldman JM, Schmitz N, Niethammer D, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumors and immune disorders: current practice in Europe in 1998. Bone Marrow Transplant 1998;21:1-7.
21. Barret AJ, Horowitz MM, Gale RP, et al. Marrow Transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989;74:862-71.
22. Weisdorf DJ, Woods WG, Nesbit ME, et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia: risk factors and clinical outcome. Br J Haematol 1994;86:62-9.
23. Collins RH, Goldstein S, Giralt S, et al. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant 2000;26:511-6.
24. Davies SM, Ramsay NKC, Klein JP, Weisdorf DJ, Bolwell B, Cahn JY, et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 2000; 18:340-7.
25. Carpenter PA, Marshall GM, Giri N, Vowels MR, Russell SJ. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan. Bone Marrow Transplant 1996;18: 489-94.
26. Ringden O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindelor L, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: A report from the Nordic Bone Marrow Transplant Group. Blood 1994;83:2723-30.
27. Pui CH, Evans WE. Acute lymphoblastic leukaemia. N Engl J Med 1998;339: 605-15.
28. Bordigoni P, Vernant JP, Souillet G, Gluckman E, Marininchi D, Milpied N, et al. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la greffe de Moelle Osseuse. J Clin Oncol 1989;7: 747-53.
29. Saarinen UM, Mellander L, Nysom K, Rindgen O, Schroeder H, Glomstein A, et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Bone Marrow Transplant. 1996;17:357-63.
30. Uderzo C, Balduzzi A, De Lorenzo P, Valsecchi MG, Gadner H, Klingebiel T, et al. Prospective study on allogeneic bone marrow transplantation (AlloBMT) versus chemotherapy (Chemo) for very high-risk (VHR) childhood acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transplant 2001;28 (suppl. 1):22-4.
31. Weyman C, Graham-Pole J, Emerson S, August C, Champlin R, Coccia P, et al. Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey. Bone Marrow Transplant 1993;11:43-50.
32. Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Laccur B, et al. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukemia after relapse while receiving chemo-therapy: a Societe Francaise de Greffe de Moelle study. Br J Haematol 1998;102:656-62.
33. Boulad F, Steinherz P, Reyes B, Heller G, Gillio AP, Small TN, et al. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study. J Clin Oncol 1999;17:197-202.
34. Blume KG, Forman SJ, O'Donnell MR, Doroshow JH, Krance RA, Nademane AP, et al. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignencies. Blood, 1987;69:1015-20.
35. Schmitz N, Gassmann W, Rister M, Johannson W, Sottorp M, Brix F, et al. Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. Blood, 1988;72:1567-73.
36. Dopfer R, Henze G, Bender-Götze C, Ebell W, Ehninger G, Friedrich W, et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFMand CoALL-Protocols: Results of the German Cooperative Study. Blood, 1991;78: 2780-4.
37. Barret AJ, Horowitz MM, Pollock BH, Zhang NJ, Bortim MM, Buchanan GR, et al. Bone marrow transplants from HLAidentical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994;331:1253-8.
38. Knechtli CJ, Goulden NJ, Hancock JP, Grandage VL, Harris EL, Garland RJ, et al. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood 1998; 92:4072-9.
39. Wheldon TE, Barrett A. Radiobiological modelling of the treatment of leukaemia by total body irradiation. Radiother Oncol 2001;58:227-33.